Large-scale harmful algal blooms (HABs) occur in the coastal waters of the northern Beibu Gulf, China, and have deleterious effects on the marine ecosystem. The frequency, duration, and extent of HAB events in this region have increased over the last 30 years. However, the underlying causes of HABs and their likely future trends are unclear. To investigate, we evaluated historical data for temporal trends of HABs in the Beibu Gulf, and association with environmental factors as possible drivers. The results confirmed that HAB events had increased in frequency, from 6 reported events during the period 1985–2000, to 13 during 2001–2010, and 20 during 2011–2017. We also found that the geographic scale of algal blooms had increased from tens of km² to hundreds of km². There were temporal changes in HAB trigger species: prior to 2000, the cyanobacteria Microcystis aeruginosa was the dominant species, while during the period 2001–2010, blooms of cyanobacteria, dinoflagellates, and diatoms co-occurred, and during 2011–2017, the haptophyte Phaeocystis globosa became the dominant algal bloom species. Principal component analysis and variation partitioning analysis indicated that nutrient discharge, industrial development, and human activities were the key drivers of HAB events, and redundancy analysis showed that variation in the algal community tended to be driven by nutrient structure. Other factors, such as shipping activities and mariculture, also contributed to HAB events and algal succession, especially to P. globosa blooms. We speculated that the increasing severity of algal blooms in the northern Beibu Gulf reflects a more complex aquatic environment and highlights the damaging effects of anthropogenic inputs, urbanization development, and an expanding industrial marine-economy on the marine ecosystem. This research provides more insight into the increase of HABs and will aid their management in the Beibu Gulf.

The worldwide increase in antibiotic-resistant pathogens means that identification of alternative antibacterial drug targets and the subsequent development of new treatment strategies are urgently required. One such new target is the quorum sensing (QS) system. Coral microbial consortia harbor an enormous diversity of microbes, and are thus rich sources for isolating novel bioactive and pharmacologically valuable natural products. However, to date, the versatility of their bioactive compounds has not been broadly explored. In this study, about two hundred bacterial colonies were isolated from a coral species (Pocillopora damicornis) and screened for their ability to inhibit QS using the bioreporter strain Chromobacterium violaceum ATCC 12472. Approximately 15% (30 isolates) exhibited anti-QS activity, against the indicator strain. Among them, a typical Gram-positive bacterium, D11 (Staphylococcus hominis) was identified and its anti-QS activity was investigated. Confocal microscopy observations showed that the bacterial extract inhibited the biofilm formation of clinical isolates of wild-type P. aeruginosa PAO1 in a dose-dependent pattern. Chromatographic separation led to the isolation of a potent QS inhibitor that was identified by high-performance liquid chromatography-mass spectrometry (HPLC-MS) and nuclear magnetic resonance (NMR) spectroscopy as DL-homocysteine thiolactone. Gene expression analyses using RT-PCR showed that strain D11 led to a significant down-regulation of QS regulatory genes (lasI, lasR, rhlI, and rhlR), as well as a virulence-related gene (lasB). From the chemical structure, the target compound (DL-homocysteine thiolactone) is an analog of the acyl-homoserine lactones (AHLs), and we presume that DL-homocysteine thiolactone outcompetes AHL in occupying the receptor and thereby inhibiting QS. Whole-genome sequence analysis of S. hominis D11 revealed the presence of predicted genes involved in the biosynthesis of homocysteine thiolactone. This study indicates that coral microbes are a resource bank for developing QS inhibitors and they will facilitate the discovery of new biotechnologically relevant compounds that could be used instead of traditional antibiotics.

Microalgae as the photosynthetic organisms offer enormous promise in a variety of industries, such as the generation of high-value byproducts, biofuels, pharmaceuticals, environmental remediation, and others. With the rapid advancement of gene editing technology, CRISPR/Cas system has evolved into an effective tool that revolutionised the genetic engineering of microalgae due to its robustness, high target specificity, and programmability. However, due to the lack of robust delivery system, the efficacy of gene editing is significantly impaired, limiting its application in microalgae. Nanomaterials have become a potential delivery platform for CRISPR/Cas systems due to their advantages of precise targeting, high stability, safety, and improved immune system. Notably, algal-mediated nanoparticles (AMNPs), especially the microalgae-derived nanoparticles, are appealing as a sustainable delivery platform because of their biocompatibility and low toxicity in a homologous relationship. In addition, living microalgae demonstrated effective and regulated distribution into specified areas as the biohybrid microrobots. This review extensively summarised the uses of CRISPR/Cas systems in microalgae and the recent developments of nanoparticle-based CRISPR/Cas delivery systems. A systematic description of the properties and uses of AMNPs, microalgae-derived nanoparticles, and microalgae microrobots has also been discussed. Finally, this review highlights the challenges and future research directions for the development of gene-edited microalgae.Graphical Abstract